Zobrazeno 1 - 10
of 16
pro vyhledávání: '"C.-H. Wauschkuhn"'
Publikováno v:
European Neuropsychopharmacology. 6:S4-65
Autor:
K. Schaffler, I. W. Reimann, Werner Herrmann, J. P. Leonard, M. Jobert, M. Böttcher, H. Ott, C. H. Wauschkuhn, B. Dietrich, M. Versavel, B. Gallhofer, Hartmut Schulz, J. Oldigs-Kerber
Publikováno v:
Klinische Neurophysiologie. 27:55-58
Publikováno v:
Agents and Actions. 36:C437-C439
The study investigated the local anaesthetic efficacy and its time course of dimethindene. The pilot-study was carried out with 8 healthy volunteers in a placebo-controlled, randomized, crossover design with four gel formulations [Dimethindene, non-o
Publikováno v:
Arzneimittel-Forschung. 48(8)
In a steady-state cross-over study in 18 healthy volunteers, the relative bioavailability of beta-escin (CAS 11072-93-8) after oral administration of a new immediate release enteric-coated test formulation containing aesculus extract was evaluated in
Publikováno v:
Arzneimittel-Forschung. 46(9)
The effects of dimethindene maleate (CAS 3614-69-5) on the central nervous system-as sustained release pellets (Fenistil OAD; OAD = once a day) and sustained release tablets (Fenistil retard) with an immediate release fraction-were investigated by me
Publikováno v:
Arzneimittel-Forschung. 42(11)
Dimetindene maleate (DMM, Fenistil, CAS 3614-69-5) a specific H1-receptor antagonist, is therapeutically used for the treatment of respiratory allergies, urticaria, itching dermatoses and generally pruritic sensations occurring with various diseases.
Publikováno v:
Arzneimittel-Forschung. 41(7)
Comparative Studies on the Bioavailability of Nicergoline from Two Different Preparations in Steady State The bioavailability of nicergoline (CAS 27848-84-6) in a new 30 mg tablet and a 10 mg dragee formulation (Sermion) was evaluated under steady st
Publikováno v:
Arzneimittel-Forschung. 41(7)
Twelve healthy young males volunteered in this pilot-study to test the encephalotropic potency of a deproteinized hemodialysate of calf blood (Actovegin). This compound contains peptides, oligosaccharides and nucleinic acid derivatives, which are sup
Publikováno v:
Arzneimittel-Forschung. 41(4)
A randomized, double-blind crossover study was performed with three different acute oral dosages of CM 40907 (3-(4-hydroxypiperidyl)-6-(2'-chlorophenyl)-pyridazine) (600, 900 and 1200 mg), a newly developed anticonvulsant drug, vs acetylsalicylic aci
Publikováno v:
Die Pharmazie. 46(2)